5 March 2013-WTO TRIPS Council-Intervention of EU on LDC request for an extension to the transition periodSubmitted by thiru on 6. March 2013 - 10:42
On 5 March 2013, the European Union delivered the following statement during WTO TRIPS Council discussions on the LDC group’s request for an extension of the transitional period for TRIPS implementation.
5 March 2013-Intervention of Nepal (LDC Group) at WTO Council for TRIPS: Request for an Extension of the Transitional PeriodSubmitted by thiru on 6. March 2013 - 3:22
On Tuesday, 5 March 2013, the Ambassador of Nepal made the following intervention at the World Trade Organization's Council for TRIPS, on behalf of the LDC Group on agenda item 11, Request for an Extension of the Transitional Period under Article 66.1 of the TRIPS Agreement.
WTO Council for TRIPS Meeting, March 5-6, 2013
Agenda item 11 – Request for an Extension of the Transitional Period under Article 66.1 of the TRIPS Agreement
Presentation of Request (IP/C/W/583) by Nepal on Behalf of LDCs Group
5 March 2013-WTO TRIPS Council-Intervention of India on LDC request for an extension to the transition periodSubmitted by thiru on 5. March 2013 - 12:34
On 5 March 2013, the Government of India made the following intervention at the TRIPS Council under agenda item 11, request for an extension of the transitional period under Article 66.1 of the TRIPS Agreement. In their intervention, India unequivocally supported the duly motivated requested submitted by Haiti on behalf of the LDC Group on 5 November 2012 (IP/C/W/583).
India asserted that the "no roll back provision" of the 2005 extension had no place in the TRIPS Agreement and noted that
5 March 2013-WTO TRIPS Council-Intervention of India on Intellectual Property and Innovation: Small and medium Sized EnterprisesSubmitted by thiru on 5. March 2013 - 12:20
On 5 March 2013, the Government of India delivered the following statement at the TRIPS Council on agenda item 13, Intellectual Property and Innovation: Small and Medium-Sized Enterprises, a standalone item tabled by Chile, Chinese Taipei, the Republic of Korea and the United States of America.
We thank the delegations of Chinese Taipei, Korea, the United States and others for tabling an agenda item on "Intellectual Property and Innovation: Small and medium Sized Enterprises" which we understand is a standalone item.
The following statement was delivered at the 19th session of the WIPO Standing Committee on the Law Of Patents (SCP) after presentations by the secretariats of WIPO, WHO and WTO on the trilateral report.
26 February 2013
TRIPS Council meeting (5-6 March 2013: LDC request for an extension to transition period and New Zealand plain packaging)Submitted by thiru on 25. February 2013 - 11:05
The following WTO airgram WTO/AIR/4075/REV.1 (22 February 2013) contains the agenda for the upcoming WTO Council for TRIPS meeting to be held in Geneva from Tuesday, 5 March 2013 to Wednesday, 6 March 2013. The March 2013 session of the TRIPS Council will discuss the LDC Group's request (IP/C/W/583) for an extension of the transitional period under Article 66.1 of the TRIPS Agreement under agenda item 11.
October 2012: Chinese comments on future work of WIPO patent committee (L&Es, patent quality and patents and health)Submitted by thiru on 25. February 2013 - 10:07
On 17 October 2012, the State Intellectual Property Office of China submitted the following comments to the Electronic Forum of WIPO's Standing Committee on the Law of Patents (SCP) in relation to the future work of the Committee. The written submission focused on: 1) Exceptions and Limitations to Patent Rights, 2. Quality of Patents and 3. Patents and Health. These points were encapsulated in China's general intervention today.
[English translation by WIPO]
WIPO patent committee to discuss patent quality (including opposition systems), L&Es and patents and healthSubmitted by thiru on 24. February 2013 - 6:15
The 19th session of the WIPO Standing Committee on the Law of Patents (SCP) meets in Geneva from 25 February 2013 to 28 February 2013. The 18th session of the SCP ended on a contentions note as WIPO member states could not agree upon the future work of the Committee. In fact, SCP 19 was initially scheduled for November 2012 but was delayed till February 2013 as WIPO's membership thought informal discussions were required to produce a successful outcome for the future work of the patent committee.
Attached below is the version of the negotiating text from 20 February 2013. It includes several new or edited footnotes. We expect the WIPO Special Session of the Standing Committee on Copyright and Related Rights (SCCR) to discuss the new text at the plenary which is scheduled to commence at 10, Wednesday, 21 February 2013.
Footnote 10 is placed within Article E of the draft treaty text on "Importation of Accessible Format Copies" which states
MEP Keller questions EU on its position on extension of WTO TRIPS Agreement transition period for Least Developed CountriesSubmitted by thiru on 19. February 2013 - 11:40
On 28 January 2013, the following question tabled by MEP Franziska Keller (Verts/ALE) to the European Union on the EU's position on extension of WTO TRIPS Agreement transition period for Least Developed Countries was made available.
As mentioned in a previous piece, the trilateral report by the secretariats of the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO), Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade, covers a lot of ground including but not limited to: 1) the global burden of disease and global health risks, 2) health and human rights, 3) access to essential medicines: an indicator for the fulfillment of the right to
On 13 April 2011, Senator Orrin Hatch (Republican-Utah) wrote a letter to then-Secretary of State, Hillary Clinton complaining about Global Fund's policy on generic procurement and compulsory licensing. With respect to procurement, Sen. Hatch asserted that Global Fund monies were used to procure generic drugs "at unnecessary costs in recipient countries" while branded drugs (all Abbott products) were were available at a lower cost.
WHO/WIPO/WTO report on Promoting Access to Medical Technologies and Innovation: Article 39.3 and the cost-sharing approachSubmitted by thiru on 6. February 2013 - 10:41
On Tuesday, 5 February 2013, the Secretariats of the World Health Organization (WHO), the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) released their joint publication, Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade. This 251-page report covers a lot of ground.
In the words of the secretariats,
WHO Director-General Chan throws down the gauntlet on the CEWG process: "Let's fight this out at the Assembly!"Submitted by thiru on 26. January 2013 - 6:38
* The author thanks Belinda Townsend, Katy Athersuch, Judit Rius Sanjuan and Alice Fabbri for their comprehensive notes during the WHO Executive Board discussion of the CEWG agenda item.